A Better Flu Vaccine Is Possible, If Team RFK Jr. Stays Out of the Way The Food and Drug Administration's approval of mFlusiva, a potentially revolutionary flu vaccine, has left many puzzled.
The bureaucratic process that brought this new shot to market is now a national news story, thanks in part to the administration's tendency to sow doubt about vaccines.
But are we seeing a genuine shift in Trump's stance on vaccinations, or just another instance of rhetoric vs. reality?